Page last updated: 2024-10-29

ketamine and Graft vs Host Disease

ketamine has been researched along with Graft vs Host Disease in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eilers, H1
Philip, LA1
Bickler, PE1
McKay, WR1
Schumacher, MA1

Other Studies

1 other study available for ketamine and Graft vs Host Disease

ArticleYear
The reversal of fentanyl-induced tolerance by administration of "small-dose" ketamine.
    Anesthesia and analgesia, 2001, Volume: 93, Issue:1

    Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Drug Therapy, Combination; Drug Tolerance; Fem

2001